Here Are My Top 4 Stocks to Buy in October

Axe Cap view

Top Four Global Growth Names to Watch, With a South African Lens

A tech and health blend worth watching for October, with rand and local bank implications.

The hype around GLP-1 weight loss drugs is global, driven by candidates like Viking Therapeutics’ monthly-dose offering. While Viking isn’t JSE-listed, investors should track rand strength (USD/ZAR)—a weaker rand could amplify costs for local pharma importers and affect consumer healthcare stocks indirectly. Alphabet’s soaring cloud AI business is another growth engine, but direct SA plays come via Prosus and Naspers, whose heavy stakes in global tech give local investors some exposure to this trend. Meanwhile, SoFi’s customer gains signal robust US fintech growth, relevant here as South African banks like Standard Bank and FirstRand cautiously eye digital expansion—highlighting the domestic sector’s need to innovate or risk falling behind. MercadoLibre’s Latin American e-commerce boom resembles Shoprite’s regional playbook; however, margin pressures warn against chasing growth blindly. My takeaway: global tech and health themes are critical but require currency and local banking sector awareness. This view might be wrong if the rand unexpectedly rebounds or local companies accelerate digital transformation faster than expected. this is just our opinion and not financial advice